AAMEAtlantic American Corporation
The schedule
- Thu1Oct
AM Best’s periodic review of Atlantic American’s capital adequacy and financial strength rating will shape counterparty and policyholder confidence; affirmation with a stable outlook could support a move back toward $1.70, while a negative outlook or downgrade would raise capital and growth costs and could pressure the shares toward $1.70.
- Tue10Nov
- Tue15Dec
Speculation that Atlantic American could explore strategic alternatives, including a sale or portfolio transaction, may build into late 2026; a credible process or announced transaction at a premium could re-rate the stock toward $1.10, while the absence of real interest or a failed process could leave micro-cap investors nursing losses closer to $0.20.
- Sun14Feb
Q4 2026 results will close out a volatile period for Atlantic American and either validate a turnaround in profitability or reinforce concerns about scale and capital efficiency; confirmation of improving returns on equity and stable loss ratios could lift the stock toward $0.60, while a weak close to the year or any new control or filing issues could push it down toward $0.60.
- Wed21Jul
Q3 2026 earnings should give the first view of how Atlantic American plans to balance growth, underwriting discipline, and capital deployment into 2027; credible guidance with improving margins could lift the stock toward $1.30, while another year of low-visibility targets or margin slippage could drag it down toward $1.30.
- Wed20Oct
Past
- Tue11Aug
Actual outcome: Bear · $1.43 at outcome
The stock closed at $1.43 on the outcome date, below the bull target of $1.90 and above the bear floor of $1.20, but the price reaction was flat from event to outcome date. The earnings report showed an EPS actual of 0.0283, matching the estimate, but the lack of positive catalysts and potential concerns over underwriting margins and disclosure issues likely pressured the stock, leading to a bearish outcome.
Q2 2026 results will show whether Atlantic American can sustain mid-teens revenue growth while keeping loss and expense ratios stable after recent reserve and reporting noise; a clean print with stable combined ratios could push the stock toward $1.90, while any deterioration in underwriting margins or further disclosure issues could see it trade back toward $1.90.
- Wed15Jul
Actual outcome: Bear · $1.58 at outcome
Atlantic American's mid-year statutory reserve and actuarial assumption review resulted in no material changes to its life and supplemental insurance liabilities or capital flexibility. Without a significant positive or negative catalyst from the review, the stock experienced a muted reaction, drifting lower by 3.1% and remaining well within the bounds of the bull and bear targets.
Mid-year review of Atlantic American’s statutory reserves and actuarial assumptions, a key check on life and supplemental insurance liabilities and capital flexibility around $1.70.
- Wed20May
Actual outcome: Bear · $1.87 at outcome
Although Atlantic American's Q1 EPS of $0.0283 met estimates, the company received a Nasdaq non-compliance notice due to a delayed Form 10-Q filing. The uncertainty surrounding the delayed financial reporting overshadowed the earnings match, driving the stock down 17.3% and well below the bear floor.
Q1 2026 results will show whether Atlantic American is sustaining the revenue acceleration seen through 2025 while stabilizing profitability, and how higher interest rates are flowing through to portfolio yields and spread income.
